Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EMvision Medical DevicesASX:EMV +4.25%20 3-1 Month Momentum % is -14.89% as of Aug. 02, 2026. GuruFocus rates ASX:EMV with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 850 Medical Devices & Instruments companies, EMvision Medical Devices ranks worse than 63.53% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-02), EMvision Medical Devices's 3-1 Month Momentum % is -14.89%.
The industry rank for EMvision Medical Devices's 3-1 Month Momentum % or its related term are showing as below:
ASX:EMV's 3-1 Month Momentum % is ranked worse than 63.53% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: -8.05
vs ASX:EMV: -14.89
EMvision Medical Devices (ASX:EMV) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
EMvision Medical Devices 3-1 Month Momentum % Related Terms
ASX:EMV vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, EMvision Medical Devices's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EMvision Medical Devices 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EMvision Medical Devices's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where EMvision Medical Devices's 3-1 Month Momentum % falls into.
EMvision Medical Devices (ASX:EMV) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EMvision Medical Devices (ASX:EMV) has a 3-1 Month Momentum % of -14.89% as of Aug. 02, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on EMvision Medical Devices and its competitors. According to the industry distribution chart, EMvision Medical Devices ranks #540 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 63.5%.
Is EMvision Medical Devices' 3-1 Month Momentum % too high?
EMvision Medical Devices' current 3-1 Month Momentum % is -14.89%. Based on the distribution chart, EMvision Medical Devices ranks #540 out of 850 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, EMvision Medical Devices has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EMvision Medical Devices ranks #540 out of 850 companies for 3-1 Month Momentum %. This places EMvision Medical Devices in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on EMvision Medical Devices and its competitors. EMvision Medical Devices's current 3-1 Month Momentum % is -14.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current 3-1 Month Momentum % of -14.89%. The current 3-1 Month Momentum % is -14.89%. EMvision Medical Devices' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current 3-1 Month Momentum % is -14.89% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
20GF Score
Get the complete analysis for ASX:EMV
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EMV has been successfully added to your 
